Insys files for bankruptcy on the heels of $225M kickback settlement with the feds
Insys Therapeutics settled with the feds for $225M on federal kickback charges, but things continue to escalate for the opioid maker.
Insys filed for Chapter 11 bankruptcy on the heels of an agreement with the Department of Justice to pay civil and criminal penalties to tie up charges that the company paid doctors to boost scripts of its fentanyl spray Subsys. Insys will look to sell almost all of its assets within 90 days.
